Effect of Implant Thread Design on Implant Stability Quotient (ISQ) in Early Healing Period

NCT02701387 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2016-12-29

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether implant thread design impacts bone remodeling and/or dental implant stability in the early healing period.

The population of this study will consist of a group of subjects who are interested in replacing two or more missing teeth with dental implants. All implant sites will be healed and not require bone augmentation for the placement of a standard 4 mm diameter implant. Subjects first will undergo a brief screening exam. If accepted, comprehensive oral exam will be completed. Subsequently, enrolled subjects will be scheduled for dental surgery to place the implant(s). Subjects will return weekly for the first 8 weeks after placement for a brief post-operative appointment in order to conduct measurements for the study.

Conditions

  • Partial Edentulism

Interventions

DEVICE

Megagen AnyRidge dental implant

AnyRidge is an approved dental implant with a knife edge, thin thread design available in various thread widths (depth).

DEVICE

Megagen EZ Plus dental implant

EZ Plus is an approved dental implant with a standard thread design (width and depth) and that is comparable to many other dental implants currently available on the market.

Sponsors & Collaborators

Principal Investigators

  • Perry R Klokkevold, DDS, MS · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-04-30
Completion
2015-04-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02701387 on ClinicalTrials.gov